Defunct Company
Total Trials
8
As Lead Sponsor
4
As Collaborator
Total Enrollment
4,116
NCT01109810
Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™)
Phase: N/A
Role: Lead Sponsor
Start: Sep 8, 2010
Completion: Jun 10, 2022
NCT01974830
AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry
Start: Oct 31, 2013
Completion: Sep 6, 2019
NCT03160846
The Inotrope Evaluation and Research Patient Registry
Start: Aug 25, 2014
Completion: Sep 30, 2021
NCT02509286
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
Phase: Phase 3
Role: Collaborator
Start: Jan 31, 2016
Completion: Dec 31, 2024
NCT02569125
Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome
Phase: Phase 2
Completion: Feb 29, 2016
NCT02396628
Ruxolitinib In GvHD
Start: Jun 29, 2017
Completion: Nov 15, 2019
NCT03885102
Dialysis Training Therapy: The DiaTT Trial
Start: Apr 1, 2019
Completion: Feb 28, 2022
NCT04035551
Health Evaluation And Learning for Total Parenteral Nutrition (TPN) at Home Patient Registry
Start: Jun 17, 2019
Completion: Jul 1, 2024